SOST, an LNGFR target, inhibits the osteogenic differentiation of rat ectomesenchymal stem cells.

about

SOST, an LNGFR target, inhibits the osteogenic differentiation of rat ectomesenchymal stem cells.

Item

http://www.wikidata.org/entity/Q47263016

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

SOST, an LNGFR target, inhibit ...... at ectomesenchymal stem cells.

@en

SOST, an LNGFR target, inhibit ...... at ectomesenchymal stem cells.

@nl

type

Item

label

SOST, an LNGFR target, inhibit ...... at ectomesenchymal stem cells.

@en

SOST, an LNGFR target, inhibit ...... at ectomesenchymal stem cells.

@nl

prefLabel

SOST, an LNGFR target, inhibit ...... at ectomesenchymal stem cells.

@en

SOST, an LNGFR target, inhibit ...... at ectomesenchymal stem cells.

@nl

P1476

SOST, an LNGFR target, inhibit ...... rat ectomesenchymal stem cells

@en

P2093

Chang Liu

http://www.w3.org/2001/XMLSchema#string

Junyu Liu

http://www.w3.org/2001/XMLSchema#string

Kun Yang

http://www.w3.org/2001/XMLSchema#string

Luchuan Liu

http://www.w3.org/2001/XMLSchema#string

Manzhu Zhao

http://www.w3.org/2001/XMLSchema#string

Xiujie Wen

http://www.w3.org/2001/XMLSchema#string

Yingying Wang

http://www.w3.org/2001/XMLSchema#string

Yong Xiao

http://www.w3.org/2001/XMLSchema#string

P2860

Prostaglandin E2 signals through PTGER2 to regulate sclerostin expression

Osteocyte control of bone formation via sclerostin, a novel BMP antagonist

Sost down-regulation by mechanical strain in human osteoblastic cells involves PGE2 signaling via EP4

Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice

Organization of the ER-Golgi interface for membrane traffic control.

Inhibiting the osteocyte-specific protein sclerostin increases bone mass and fracture resistance in multiple myeloma

Inhibitors of sclerostin: emerging concepts.

Diabetes reduces mesenchymal stem cells in fracture healing through a TNFα-mediated mechanism

Parathyroid hormone (PTH)-induced bone gain is blunted in SOST overexpressing and deficient mice

Acute decline in serum sclerostin in response to PTH infusion in healthy men.

P304

e12412

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CPR.12412

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gang Li

P577

2017-12-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29226516

http://www.w3.org/2001/XMLSchema#string

P932

6528939

http://www.w3.org/2001/XMLSchema#string